Research output per year
Research output per year
Personal profile
Biography
Elizabeth Johnstone obtained her PhD in Pharmacology from the University of Western Australia (UWA) in 2016. Since then she has been working as a postdoctoral researcher at the Harry Perkins Institute of Medical Research/UWA Centre for Medical Research where she studies the molecular pharmacology of receptors. In 2021 she was appointed as a Pharmacology Lecturer in the UWA School of Biomedical Sciences, while she continues her research at the Harry Perkins Institute of Medical Research.
Roles and responsibilities
Chair, UWA Pharmacology and Toxicology Research Committee (2021 - present)
Member, Space and Accommodation Committee, UWA School of Biomedical Sciences (2021 – present)
Teaching overview
- PHAR3310 Molecular Pharmacology, lecturer
- PHAR3311 Molecular Pharmacology Methods, tutor
- PHAR3320 Systems Pharmacology Methods, unit coordinator
- PHAR3321 Systems Pharmacology Methods, unit coordinator
Research interests
Receptor signalling, assay development, bioluminescence resonance energy transfer
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Pharmacology, PhD, Biophysical insights into the molecular pharmacology of angiotensin II receptor heteromers, The University of Western Australia
Award Date: 7 Apr 2016
Pharmacology, Honours Degree (First Class), Heteromerisation with the bradykinin type 2 receptor alters brta-arrestin recruitment and internalisation of the angiotensin II type 2 receptor, The University of Western Australia
Award Date: 15 Dec 2011
BSc, Biochemistry and Pharmacology, The University of Western Australia
Award Date: 11 Dec 2009
External positions
Education Representative, Innovation and Industry Special Interest Group , Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists
2022 → …
Member, ASM Program Organising Committee , Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists
2022 → …
Education Representative, Drug Discovery Special Interest Group , Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists
2021 → …
Early Career Committee and Basic Science Representative, ASM Program Organising Committee, Endocrine Society of Australia
2021 → …
Member, Early Career Researcher Committee, Harry Perkins Institute of Medical Research
2020 → …
Ex-Officio Council Member, Endocrine Society of Australia
2019 → …
Chair of Basic Science, Early Career Committee , Endocrine Society of Australia
2019 → …
Western Australian Representative, Drug Discovery Special Interest Group , Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists
2017 → …
Fingerprint
Dive into the research topics where Liz Johnstone is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
GPCR heteromers: An overview of their classification, function and physiological relevance
Dale, N. C., Johnstone, E. K. M. & Pfleger, K. D. G., 30 Aug 2022, In: Frontiers in Endocrinology. 13, 13 p., 931573.Research output: Contribution to journal › Review article › peer-review
Open Access8 Citations (Scopus) -
Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor
Johnstone, E. K. M., Ayoub, M. A., Hertzman, R. J., See, H. B., Abhayawardana, R. S., Seeber, R. M. & Pfleger, K. D. G., 26 May 2022, In: Frontiers in Endocrinology. 13, 848816.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Orexin Signaling: A Complex, Multifaceted Process
Dale, N. C., Hoyer, D., Jacobson, L. H., Pfleger, K. D. G. & Johnstone, E. K. M., 13 Apr 2022, In: Frontiers in Cellular Neuroscience. 16, 812359.Research output: Contribution to journal › Review article › peer-review
Open Access9 Citations (Scopus) -
Article investigation of receptor heteromers using nanobret ligand binding
Johnstone, E. K. M., See, H. B., Abhayawardana, R. S., Song, A., Rosengren, K. J., Hill, S. J. & Pfleger, K. D. G., 1 Feb 2021, In: International Journal of Molecular Sciences. 22, 3, p. 1-16 16 p., 1082.Research output: Contribution to journal › Article › peer-review
Open Access7 Citations (Scopus) -
Complex interactions between the angiotensin II type 1 receptor, the epidermal growth factor receptor and TRIO-dependent signaling partners
Johnstone, E. K. M., Abhayawardana, R. S., See, H. B., Seeber, R. M., O'Brien, S. L., Thomas, W. G. & Pfleger, K. D. G., Jun 2021, In: Biochemical Pharmacology. 188, 114521.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)
-
TARGETING A NEW SUBTYPE OF ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Blancafort, P., Redfern, A., Golden, E., Johnstone, L., Pavlos, N. & Sharma, A.
National Breast Cancer Foundation
31/05/22 → 31/05/26
Project: Research